[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100606707":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":11,"centralContacts":28,"locations":33,"responsibleParty":95,"collaborators":11,"id":97,"slug":98,"hasResults":99,"nctId":100,"briefTitle":101,"officialTitle":102,"acronym":11,"eligibilityCriteria":103,"healthyVolunteers":99,"sex":104,"minAge":105,"maxAge":11,"enrollmentInfo":106,"targetDuration":11,"studyType":109,"phases":110,"briefSummary":112,"conditions":113,"keywords":11,"overallStatus":36,"whyStopped":11,"lastUpdateSubmitDate":115,"lastUpdatePostDateStruct":116,"startDateStruct":119,"completionDateStruct":121,"leadSponsor":123,"locationsCount":124},{"fullName":5,"class":6},"Vanda Pharmaceuticals","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"VSJ-110 Solution","EXPERIMENTAL",null,[13],"Drug: VSJ-110",{"label":15,"type":16,"description":11,"interventionNames":17},"Placebo Solution","PLACEBO_COMPARATOR",[18],"Drug: Placebo",[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":11},"DRUG","VSJ-110","ophthalmic solution",[9],{"type":21,"name":26,"description":23,"armGroupLabels":27,"otherNames":11},"Placebo",[15],[29],{"name":5,"role":30,"phone":31,"phoneExt":11,"email":32},"CONTACT","202-734-3400","clinicaltrials@vandapharma.com",[34,50,62,73,84],{"facility":35,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Vanda Investigational Site","RECRUITING","Newport Beach","California","92663","United States","US",{"type":43,"coordinates":44},"Point",[45,46],-117.92895,33.61891,{"lat":46,"lon":45},[49],{"name":5,"role":30,"phone":31,"phoneExt":11,"email":11},{"facility":35,"status":51,"city":52,"state":53,"zip":54,"country":40,"countryCode":41,"cosmosGeoPoint":55,"geoPoint":59,"contacts":60},"NOT_YET_RECRUITING","Andover","Massachusetts","01810",{"type":43,"coordinates":56},[57,58],-71.137,42.65843,{"lat":58,"lon":57},[61],{"name":5,"role":30,"phone":31,"phoneExt":11,"email":11},{"facility":35,"status":51,"city":63,"state":64,"zip":65,"country":40,"countryCode":41,"cosmosGeoPoint":66,"geoPoint":70,"contacts":71},"Shelby","North Carolina","28150",{"type":43,"coordinates":67},[68,69],-81.53565,35.29235,{"lat":69,"lon":68},[72],{"name":5,"role":30,"phone":31,"phoneExt":11,"email":11},{"facility":35,"status":36,"city":74,"state":75,"zip":76,"country":40,"countryCode":41,"cosmosGeoPoint":77,"geoPoint":81,"contacts":82},"Memphis","Tennessee","38119",{"type":43,"coordinates":78},[79,80],-90.04898,35.14953,{"lat":80,"lon":79},[83],{"name":5,"role":30,"phone":31,"phoneExt":11,"email":11},{"facility":35,"status":51,"city":85,"state":86,"zip":87,"country":40,"countryCode":41,"cosmosGeoPoint":88,"geoPoint":92,"contacts":93},"Lynchburg","Virginia","24502",{"type":43,"coordinates":89},[90,91],-79.14225,37.41375,{"lat":91,"lon":90},[94],{"name":5,"role":30,"phone":31,"phoneExt":11,"email":11},{"type":96,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100606707","phase-2-an-eight-week-study-to-evaluate-the-safety-and-efficacy-of-vsj-110-compared-to-placebo-in-the-treatment-of-dry-eye-100606707",false,"NCT07179055","An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye","An Eight-Week, Double-Masked, Randomized, Placebo-Controlled, Phase 2, Evaluation of the Safety and Efficacy of VSJ-110 Ophthalmic Solution in the Treatment of Dry Eye","Inclusion Criteria:\n\n* Be at least 18 years of age of either gender and any race.\n* Provide written informed consent and sign the HIPAA form.\n* Be willing and able to follow all instructions and attend all study visits.\n\nExclusion Criteria:\n\n* Use of any of the disallowed medications during the washout and study period.","ALL","18 Years",{"count":107,"type":108},160,"ESTIMATED","INTERVENTIONAL",[111],"PHASE2","The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye.",[114],"Dry Eye","2025-09-10",{"date":117,"type":118},"2025-09-17","ACTUAL",{"date":120,"type":108},"2025-10",{"date":122,"type":108},"2026-09",{"name":5,"class":6},5]